Trial Profile
Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease: A Prospective, Randomized, Controlled Trial With 5-year Follow up
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jun 2018
Price :
$35
*
At a glance
- Drugs Lidocaine/prilocaine (Primary) ; Methyl aminolevulinate (Primary)
- Indications Bowen's disease
- Focus Therapeutic Use
- 08 Jun 2018 New trial record
- 29 May 2018 Results (n=60) published in the Journal of the American Academy of Dermatology.